¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019³âµµ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Ã߰迬¼ö±³À° : 2019-10-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019³âµµ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Ã߰迬¼ö±³À° : 2019-10-31
±³À°ÀÏÀÚ : 2019-10-31
±³À°Àå¼Ò : ÀÎõ, ÆĶó´ÙÀ̽º½ÃƼȣÅÚ Room2 ¿Ü  
±³À°ÁÖÁ¦ : 2019³âµµ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Ã߰迬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ
´ã´çÀÚ : ÇÑÁÖÈñ
¿¬¶ôó : 02-795-5129  
À̸ÞÀÏ : anesthesia@kams.or.kr      
±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú      
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ÀÎõ±¤¿ª½Ã
±³À°½Ã°£ : 15 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í ¸¶ÃëÅëÁõÀÇÇаú Àü¹®ÀÇ, ŸÇаú Àü¹®ÀÇ, ÀÓ»ó°­»ç ₩100,000 ₩120,000 ₩150,000 ¸¶ÃëÅëÁõÀÇÇаú Àü°øÀÇ, ŸÇаú Àü°øÀÇ ₩80,000 ₩90,000 ₩100,000 ±ºÀÇ°ü, °øÁߺ¸°ÇÀÇ»ç ₩30,000 ₩50,000 ₩70,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 09:00~09:25 Monitoring of EEG & cerebral O2 saturation  Michael A. Ramsay (Baylor Scott & White Health Care) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 09:25~09:50 Clinical practice & outcomes in blood sugar control during cardiac surgery   Keisuke Nakazawa(Tokyo Women¡¯s Medical University Hospital) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 09:50~10:15 Neuromuscular blocking agents in ERAS protocols: faster onset or safer reversal?  Radmilo Jankovic(University of Niš) 
Åä·Ð 10-31 Room 2 (Grandballroom B) 10:15~10:30 Q&A  () 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 09:00~09:20 Why filtered, irradiated or washed blood products  ¹®¿µÁø(¿ï»ê´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 09:20~09:40 Restrictive vs liberal RBC transfusion strategy  ±¸º»¼º(¼øõÇâ´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 09:40~10:00 Point-of-care tests for non-RBC blood transfusion  ±Ç¿ø°æ(°Ç±¹´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 10:00~10:20 Core temperature monitoring & prewarming  ¼ºÅÂÀ±(°Ç¾ç´ëÇб³) 
Åä·Ð 10-31  10:20~10:30 Q&A  () 
±³À°½Ã°£ 10-31 Room 4 (Emerald A) 09:00~09:20 Multimodal analgesia for postoperative pain  ±è¼¼¿µ(°æºÏ´ëÇб³) 
±³À°½Ã°£ 10-31 Room 4 (Emerald A) 09:20~09:40 Postoperative pain control in pediatric patients  ±èÀºÈñ(¼­¿ï´ëÇб³) 
±³À°½Ã°£ 10-31 Room 4 (Emerald A) 09:40~10:00 Radiation protection in pain clinic  ±èÀçÇå(°Ç±¹´ëÇб³) 
±³À°½Ã°£ 10-31 Room 4 (Emerald A) 10:00~10:20 Ultrasound-guided nerve block for postoperative pain control  º¯°æÁ¶(ºÎ»ê´ëÇб³) 
Åä·Ð 10-31  10:20~10:30 Q&A  () 
±³À°½Ã°£ 10-31 Room 5 (Emerald B) 09:00~09:20 Fundamental pharmacodynamic principles   ÃÖº´¹®(¿ï»ê´ëÇб³) 
±³À°½Ã°£ 10-31 Room 5 (Emerald B) 09:20~09:40 Principles of target-controlled infusion   ÀÌÇüö(¼­¿ï´ëÇб³) 
±³À°½Ã°£ 10-31 Room 5 (Emerald B) 09:40~10:00 Dosage titration based on patient characteristics  À̼ºÇå(Àü³²´ëÇб³) 
±³À°½Ã°£ 10-31 Room 5 (Emerald B) 10:00~10:20 NM monitoring basics & updates  ±èÁÖ´ö(°í½Å´ëÇб³) 
Åä·Ð 10-31  10:20~10:30 Q&A  () 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 11:00~11:25 Innovations in regional anaesthesia- an evidence-based review  Vincent Chan(University of Toronto) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 11:25~11:50 Enhanced recovery for total joint replacement  Jeff Gadsden(Duke University Medical Center) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 11:50~12:15 Postoperative thromboprophylaxis, the current evidence   Hans D. De Boer(Martini Hospital) 
Åä·Ð 10-31  12:15~12:30 Q&A  () 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 11:00~11:20 Perioperative ¥â-blockers & ACE inhibitors or ARBs  ¿ÀÃæ½Ä(°Ç±¹´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 11:20~11:40 Cerebral perfusion pressure & position  ¹ÚÈñÆò(¼­¿ï´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 11:40~12:00 Prevention & treatment of anesthesia-induced hypotesion  ÀÌÁ¾È¯(¼º±Õ°ü´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 12:00~12:20 Management for geriatric patients with diastolic dysfunction  ¼Û¼®¿µ(´ë±¸Ä«Å縯´ëÇб³) 
Åä·Ð 10-31  12:20~12:30 Q&A  () 
½Ä»ç 10-31  12:30~13:30 Lunch  () 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 13:30~13:55 Preoperative assessment for pulmonary resection  Peter Slinger(Toronto General Hospital) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 13:55~14:20 Anesthesia for esophagectomy  Randal S. Blank(University of Virginia Health System) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 14:20~14:45 Are PEEP & recruitment maneuvers in the operating room obsolete?  Marcelo Gama de Abreu(Dresden University of Technology) 
Åä·Ð 10-31  14:45~15:00 Q&A  () 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 13:30~13:50 Hemodynamic management during cardiopulmonary bypass  ³²»ó¹ü(¿¬¼¼´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 13:50~14:10 Anti-coagulation during cardiopulmonary bypass  Á¶À±Á¤(¼­¿ï´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 14:10~14:30 Weaning from cardiopulmonary bypass  ±è¼ºÇù(°Ç±¹´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 14:30~14:50 Management of reperfusion period in liver transplantation  ¼ÛÁØ°É(¿ï»ê´ëÇб³) 
Åä·Ð 10-31  14:50~15:00 Q&A  () 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 15:30~15:50 Evaluation of postoperative neurocognitive dysfunction & delirium   ±¸º»³à(¿¬¼¼´ëÇб³) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 15:50~16:10 Basics of high flow nasal cannula   ÀÌÇѳª(¼­¿ï´ëÇб³) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 16:10~16:30 Hemodynamic management for sepsis   ÀÓÃáÇÐ(°í·Á´ëÇб³) 
±³À°½Ã°£ 10-31 Room 2 (Grandballroom B) 16:30~16:50 Infection in critical care   ±èÁ¤¹Î(¿¬¼¼´ëÇб³) 
Åä·Ð 10-31  16:50~17:00 Q&A  () 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 15:30~15:50 Perioperative management of pediatric patients with URI   ÀÓº´°Ç(°í·Á´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 15:50~16:10 Double-lumen tube vs blocker for one-lung ventilation   ±èÈñÁÖ(°í·Á´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 16:10~16:30 Intraoperative ventilation in pediatric patients   ÀÌÁ¤¸²(¿¬¼¼´ëÇб³) 
±³À°½Ã°£ 10-31 Room 3 (Grandballroom A) 16:30~16:50 MAC for radiologic imaging in pediatric patients   ±è¹Î¼ö(¿¬¼¼´ëÇб³) 
Åä·Ð 10-31  16:50~17:00 Q&A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019³âµµ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ Ã߰迬¼ö±³À° : 2019-10-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç±¹´ëÇб³º´¿ø ´ëÇѺÎÁ¤¸ÆÇÐȸ Á¦ 4Â÷ °³¿øÀÇ ¹× Àü°øÀǸ¦ À§ÇÑ ºÎÁ¤¸Æ ¿¬¼ö°­Á : 2019-10-31
´ÙÀ½±Û 2019³âµµ Á¦ 4ȸ ´ëÇѼÒÈ­±âÇÐȸ ÀüºÏÁöȸ ¿¬¼ö°­Á : 2019-10-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
300 ¼­¿ï ´ëÇѳëÀκ´ÇÐȸ Á¦ 38Â÷ ÀÎÁ¤ÀÇ ¿¬¼ö°­Á : 2018-08-19 0 772 2018-08-08
299 ¼­¿ï 2018 ÀÇ·áÄ¿¹Â´ÏÄÉÀÌ¼Ç ±³À°Àü·« ¿öÅ©¼ó : 2018-08-18 0 541 2018-08-08
298 °æ±â ´ëÇÑôÃßÁ¾¾ç¿¬±¸È¸ Á¦18Â÷ Çмú´ëȸ : 2018-08-18 0 1,034 2018-08-08
297 ¼­¿ï ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ iTHA (Innovation & Technology in Hip Athroplasty) : 2018-08-18 0 1,208 2018-08-08
296 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-18 0 612 2018-08-08
295 ¼­¿ï °æÈñ´ëÇб³º´¿ø 2018 Kyung Hee Neurosurgery Symposium (ÀÓ¿µÁø ±³¼ö´Ô Á¤³â±â³ä ½ÉÆ÷Áö¿ò) : 2018-08-18 0 1,541 2018-08-08
294 °æ±â ´ëÇÑ°³¿øÀÇÇùÀÇȸ °­¿øÁöȸ ½ÉÆ÷Áö¿ò : 2018-08-18 0 636 2018-08-08
293 ¼­¿ï ´ëÇÑÈäºÎ¿Ü°úÇÐȸ Heart Valve Disease Symposium 2018 : 2018-08-17 0 1,094 2018-08-08
292 ¼­¿ï °æÈñ´ëÇб³º´¿ø Á¦11ȸ »êºÎÀΰú-¼Ò¾Æû¼Ò³â°ú ¼±»ý´Ôµé°ú ÇÔ²²ÇÏ´Â ¿ù·ÊÁý´ãȸ : 2018-08-17 0 926 2018-08-08
291 °­¿ø °­¿øµµÀÇ»çȸ ÀúÇ÷´çÁõ¿¡ ´ëÇÑ °íÂû : 2018-08-16 0 563 2018-08-08
290 ¼­¿ï ´ëÇѽÅÀåÇÐȸ 2018 Update on CKD-MBD: Phosphorous and Magnesium in health and disease : 2018-09-30 0 1,160 2018-07-28
289 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø °³¿øÀǸ¦ À§ÇÑ ¼Ò¾ÆÁúȯ : 2018-09-29 0 880 2018-07-28
288 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : ¿¬±Ø¼º ÀΰÝÀå¾Ö, ÀÇÁ¸¼º ÀΰÝÀå¾Ö : 2018-09-29 0 1,254 2018-07-28
287 ¼­¿ï 2018 ´ëÇÑâ»óÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2018-09-29 0 628 2018-07-28
286 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(CSC treatment update) : 2018-09-28 0 1,115 2018-07-28
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷